- In February 2024, Johnson & Johnson MedTech, a prominent leader in eye health, introduced the TECNIS PureSee presbyopia-correcting intraocular lens (IOL) across the EMEA region. Featuring a purely refractive design, the TECNIS PureSee IOL delivers seamless, high-quality vision with outstanding contrast sensitivity and low-light performance. It offers visual clarity comparable to monofocal lenses while addressing presbyopia, setting a new benchmark in advanced lens technology
- In September 2024, Alcon, a global leader in eye care committed to enhancing vision, unveiled new innovations at the European Society of Cataract and Refractive Surgeons (ESCRS) Annual Meeting in Barcelona. Among the highlights was the launch of the SMARTCataract DX digital planning solution—powered by the ARGOS Biometer and upcoming Alcon diagnostic tools—aimed at optimizing clinical workflows and improving procedural efficiency for ophthalmic practices
- In September 2024, Johnson & Johnson, a global leader in eye health, has announced the expanded U.S. rollout of its latest innovation in presbyopia-correcting intraocular lenses (PC-IOL), the TECNIS Odyssey. This next-generation full-range IOL provides patients with seamless, continuous vision across all distances—from far to near and everything in between significantly reducing dependence on glasses
